James C. Czirr, Executive Chairman at GALECTIN THERAPEUTICS INC (GALT), bought 10,000 shares at $2.25 ($23K) on 2012-05-17, disclosed to the SEC on 2012-05-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| GALT | SELL | 2022-08-09 | $21K | — | Filing → |
| GALT | SELL | 2021-08-03 | $33K | — | Filing → |
| GALT | SELL | 2021-05-04 | $109K | — | Filing → |